ARIZEST (SINGAPORE) PRIVATE LIMITED

Business Description

ARIZEST (SINGAPORE) PRIVATE LIMITED is registered as a business entity on 06 October 2008 (16.2 years ago) structured as a Private Company Limited By Shares (Local Company) with 5 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 200819424Z. The business official address is located at 12 Tannery Road #10-01, Hb Centre 1, Singapore 347722 in the primary industry of 64202: Other Holding Companies using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as BIOMAB PHARMACEUTICALS (SINGAPORE) PTE. LTD., MABPHARM (SINGAPORE) PRIVATE LIMITED. The business annual account filing date falls on 31 October and is currently operational with the status of 'Live Company'. The business paid up share capital is USD 25,000,000, with preference share capital of USD 0, and other share capital at USD 0.

In the past 365 days, ARIZEST (SINGAPORE) PRIVATE LIMITED has received a total of Login to view reported payment review(s). 7 were rated Good and Login to view were rated Poor. The latest review was made on 2023-05-29 and it was reported "Good". The aggregated good payment amount is equivalent to USD 1,960, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is currently active, it also signals positive financial standing. The appointment of ENTERPRISE ACCOUNTANTS LLP as auditor indicates that the business is medium to large sized as it is required to meet additional regulatory requirements either due to reported revenue or assets exceeding SGD 10 million or has more than 50 employees in the previous two fiscal years.

ARIZEST (SINGAPORE) PRIVATE LIMITED is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023